Craig Muhlhauser
Analyst · Matt Sheerin from Stifel, Nicolaus
Well, clearly -- Matt, it's Craig. The investments we've been making in diversified have begun to show significant payoff. This specific investment builds capability and the margins for which we expect to deliver in this segment are enhanced. By adding this capability, it's a higher value-added capability that we believe we cannot only leverage in semiconductor equipment but outside of that, in the complex mechanical space. We are seeing the hypothesis, the thesis around our Brooks investment, in that the strength of the offering is dramatically improved in the eyes of our customers. So it is growing very rapidly relative to the other segments, given the acquisition. With, now, the D&H acquisition, we would expect semiconductor cap complex mechanical, I think you can think of it more in the future, at least, at this point in time, to begin to emerge as the fastest-growing largest segment. But again, not -- and capability not totally focused on semi cap. And the real objective here is to build a portfolio of capabilities in health care, aerospace and defense, semiconductor equipment and industrial that leverages a large vertical called complex mechanical systems capability to be a very, very strong part of the diversified mix, frankly. So that's the strategy. That's the thesis. And we are definitely beginning to see significant benefits. So the concentration is clearly something we've recognized as an important risk to manage. Another reason, as Paul mentioned, why we've taken an additional actions on the restructuring is to make sure our fixed cost base is in line with the DNA of Celestica, to maintain the flexibility to deliver our return objectives over an economic cycle. So all in all, it's -- we think it's a very, very sound strategy. We're very excited about it. And notwithstanding the RIM challenge, we think the real focus now is on the future and accelerating our progress.